BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31532458)

  • 1. In Vivo Imaging of Translocator Protein in Long-term Cannabis Users.
    Da Silva T; Hafizi S; Watts JJ; Weickert CS; Meyer JH; Houle S; Rusjan P; Mizrahi R
    JAMA Psychiatry; 2019 Dec; 76(12):1305-1313. PubMed ID: 31532458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms.
    Braga J; Lepra M; Kish SJ; Rusjan PM; Nasser Z; Verhoeff N; Vasdev N; Bagby M; Boileau I; Husain MI; Kolla N; Garcia A; Chao T; Mizrahi R; Faiz K; Vieira EL; Meyer JH
    JAMA Psychiatry; 2023 Aug; 80(8):787-795. PubMed ID: 37256580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
    Setiawan E; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Rajkowska G; Suridjan I; Kennedy JL; Rekkas PV; Houle S; Meyer JH
    JAMA Psychiatry; 2015 Mar; 72(3):268-75. PubMed ID: 25629589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.
    Rathitharan G; Truong J; Tong J; McCluskey T; Meyer JH; Mizrahi R; Warsh J; Rusjan P; Kennedy JL; Houle S; Kish SJ; Boileau I
    Addict Biol; 2021 Jan; 26(1):e12876. PubMed ID: 32017280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study.
    Setiawan E; Attwells S; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Xu C; Sharma S; Kish S; Houle S; Meyer JH
    Lancet Psychiatry; 2018 Apr; 5(4):339-347. PubMed ID: 29496589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.
    Attwells S; Setiawan E; Wilson AA; Rusjan PM; Mizrahi R; Miler L; Xu C; Richter MA; Kahn A; Kish SJ; Houle S; Ravindran L; Meyer JH
    JAMA Psychiatry; 2017 Aug; 74(8):833-840. PubMed ID: 28636705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating TSPO levels in occupation-related posttraumatic stress disorder.
    Watling SE; Gill T; Gaudette EV; Richardson JD; McCluskey T; Tong J; Meyer JH; Warsh J; Jetly R; Hutchison MG; Rhind SG; Houle S; Kish SJ; Boileau I
    Sci Rep; 2023 Mar; 13(1):4970. PubMed ID: 36973385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [
    Boileau I; Mansouri E; Williams B; Le Foll B; Rusjan P; Mizrahi R; Tyndale RF; Huestis MA; Payer DE; Wilson AA; Houle S; Kish SJ; Tong J
    Biol Psychiatry; 2016 Nov; 80(9):691-701. PubMed ID: 27345297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging translocator protein (TSPO) in autism spectrum disorder.
    Simpson D; Gharehgazlou A; Da Silva T; Labrie-Cleary C; Wilson AA; Meyer JH; Mizrahi R; Rusjan PM
    Neuropsychopharmacology; 2022 Jun; 47(7):1421-1427. PubMed ID: 35383319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study.
    Da Silva T; Hafizi S; Rusjan PM; Houle S; Wilson AA; Prce I; Sailasuta N; Mizrahi R
    J Psychiatry Neurosci; 2019 Mar; 44(2):111-119. PubMed ID: 30255837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron-emission tomography imaging of the TSPO with [(18)F]FEPPA in a preclinical breast cancer model.
    Vasdev N; Green DE; Vines DC; McLarty K; McCormick PN; Moran MD; Houle S; Wilson AA; Reilly RM
    Cancer Biother Radiopharm; 2013 Apr; 28(3):254-9. PubMed ID: 23350894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSPO expression and brain structure in the psychosis spectrum.
    Hafizi S; Guma E; Koppel A; Da Silva T; Kiang M; Houle S; Wilson AA; Rusjan PM; Chakravarty MM; Mizrahi R
    Brain Behav Immun; 2018 Nov; 74():79-85. PubMed ID: 29906515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users.
    Ceccarini J; Kuepper R; Kemels D; van Os J; Henquet C; Van Laere K
    Addict Biol; 2015 Mar; 20(2):357-67. PubMed ID: 24373053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional brain abnormalities associated with long-term heavy cannabis use.
    Yücel M; Solowij N; Respondek C; Whittle S; Fornito A; Pantelis C; Lubman DI
    Arch Gen Psychiatry; 2008 Jun; 65(6):694-701. PubMed ID: 18519827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [
    Vignal N; Cisternino S; Rizzo-Padoin N; San C; Hontonnou F; Gelé T; Declèves X; Sarda-Mantel L; Hosten B
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29875332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein.
    Gershen LD; Zanotti-Fregonara P; Dustin IH; Liow JS; Hirvonen J; Kreisl WC; Jenko KJ; Inati SK; Fujita M; Morse CL; Brouwer C; Hong JS; Pike VW; Zoghbi SS; Innis RB; Theodore WH
    JAMA Neurol; 2015 Aug; 72(8):882-8. PubMed ID: 26052981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [
    Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M
    Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between TSPO-a neuroimmune marker-and redox status in clinical high risk for psychosis: a PET-MRS study.
    Hafizi S; Da Silva T; Meyer JH; Kiang M; Houle S; Remington G; Prce I; Wilson AA; Rusjan PM; Sailasuta N; Mizrahi R
    Neuropsychopharmacology; 2018 Jul; 43(8):1700-1705. PubMed ID: 29748630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid amide hydrolase is lower in young cannabis users.
    Jacobson MR; Watts JJ; Da Silva T; Tyndale RF; Rusjan PM; Houle S; Wilson AA; Ross RA; Boileau I; Mizrahi R
    Addict Biol; 2021 Jan; 26(1):e12872. PubMed ID: 31960544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress-induced cortical dopamine response is altered in subjects at clinical high risk for psychosis using cannabis.
    Schifani C; Pruessner J; Tseng HH; Rao N; Tagore A; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Addict Biol; 2020 Jul; 25(4):e12812. PubMed ID: 31389139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.